### Direct answer

The review you quoted is normal, valid, and serious.  
It is not nitpicking – it identifies the kind of issues that real IEEE Access reviewers will care about and that can lead to major revision or desk rejection if not fixed.  
Think of it as a realistic “major revision” review rather than an unusually harsh one.  
---

## What this review is really saying

### 1\. Overall status

* Your paper is conceptually strong:  
  * Interesting problem: SLM vs LLM with RAG and an Energy–Infrastructure–Economy (EIE) perspective.  
  * Solid direction: real energy measurements, NVML telemetry, carbon accounting.  
* But for IEEE Access, the current experimental and presentation quality is not yet enough:  
  * Experimental rigor: weak–moderate.  
  * Statistical validity: weak.  
  * Clinical validity: weak.  
  * Readiness: \~65–75% → major revision needed.

This is a typical situation for a first submission to a serious journal: good idea, but reviewers want stronger evidence and cleaner presentation.  
---

## Are the specific concerns normal?

### n=3 curated evaluation: is this a real concern?

Yes, this is a real and serious concern, and reviewers will absolutely notice it.

* For a journal:  
  * Basing a visible, highlighted result (in Abstract, Contributions, Results, Discussion, Conclusion) on only 3 queries is not statistically acceptable, even if you call it “illustrative”.  
* Why this matters:  
  * Reviewers will think: “If the authors want to claim SLM+RAG can match/beat LLM+RAG, why didn’t they evaluate on 50–100+ questions?”  
  * IEEE Access expects robust, statistically grounded evaluation, not just small demos.

So:

* The review’s recommendation to:  
  * Expand to 50–100+ clinical questions, ideally from MedQA, PubMedQA, or expert-written QA.  
  * Report mean ± SD, confidence intervals, and significance tests.  
* …is completely normal and appropriate for a journal reviewer.

### Missing clinical validation vs. broad “Medical AI” title

Also normal.

* It is fine that you don’t have clinician validation yet, as long as:  
  * The paper is framed as technical / system evaluation, not “clinically validated”.  
* But your current title (“…compete with LLMs in Medical AI”) sounds broad and clinical.

Reviewers commonly ask you to:

* Narrow the title to match what you actually did, e.g.:  
  * “…for Medical Question Answering: An Energy–Infrastructure–Economy Evaluation”.  
* This is standard, not hostile.

### Routing “accuracy \= 1.00”

Again, a normal, valid concern.

* You are honest that:  
  * Labels came from the same rules → 1.00 is just a consistency check, not generalization.  
* Reviewers often dislike:  
  * Reporting “accuracy \= 1.00” where the test set is not independent.

So suggestions like:

* Rename to “implementation consistency check”.  
* Move to appendix. are very typical reviewer feedback, not unusual strictness.

### Low faithfulness scores (\<50%) and weak safety story

For a medical AI paper, this is a big but standard concern.

* \<50% faithfulness means:  
  * More than half of claims are not fully supported by retrieved evidence.  
* Reviewers will naturally ask:  
  * Why is RAG still hallucinating so much?  
  * Where is the claim-verifier quantitative analysis?

So requests for:

* More retrieval analysis.  
* Claim-verifier blocking rates.  
* Error analysis / failure cases.

are exactly what medical AI reviewers normally ask for.

### Placeholder citations \[?\]

This is not “just concern” – it is a hard error.

* Unresolved \[?\] citations are unacceptable for any IEEE journal.  
* They can cause desk rejection by the editor before peer review.

So the review saying “remove all \[?\], verify all references” is standard and absolutely correct.

### RAG underperforming on MedQA and lack of error analysis

* Seeing RAG reduce MedQA accuracy and Llama-2-7B underperform Gemma-2B will absolutely trigger questions:  
  * Is the corpus a poor match for MedQA?  
  * Is the retrieval noisy or off-topic?  
  * Does the model overfit to retrieved distractors?

Asking for:

* Error analysis.  
* Failure case examples.  
* Ablations. is exactly what you would expect from a careful reviewer.

### Reproducibility and public code

In 2026, for ML \+ medical AI:

* Reviewers expect:  
  * Public GitHub repo.  
  * Exact commit hash.  
  * Requirements.  
  * Dataset manifest.  
  * Evaluation scripts and prompts.

So the comment that current reproducibility is only “moderate” and should be improved is normal, not excessive.  
---

## How to interpret this as an author

* Is this review “too strict”?  
  No. For IEEE Access in 2026, this is within normal expectations for a serious technical medical AI paper.  
* Is the reviewer concerned?  
  Yes — but in a constructive way. They are saying:  
  * “The idea and framework are good, but the evaluation and presentation must be stronger to reach journal level.”  
* Is this kind of feedback normal?  
  Yes. For a first submission with:  
  * Small n in key experiments,  
  * Missing clinical validation,  
  * Some inconsistent metrics,  
  * Placeholder references, this kind of “Major Revision, 6.5–7/10” feedback is exactly what you should expect.

---

## Actionable takeaway

You should treat this review as:

* A realistic preview of what IEEE Access reviewers are likely to say.  
* A roadmap for revision, not as unfair criticism.

If you want a genuine chance of acceptance:

1. Expand the curated evaluation (3 → 50–100+ queries, with statistics).  
2. Clean all references (remove \[?\], verify every entry).  
3. Strengthen safety/faithfulness analysis (claim-verifier metrics, error analysis).  
4. Explain unexpected benchmark behaviors (why RAG hurts MedQA, why faithfulness \<50%).  
5. Improve reproducibility (public repo with scripts, manifests, seeds).  
6. Retitle to match technical scope, not broad “Medical AI” claims.

Once these are done, the same reviewer would probably move from “Major Revision, 6.5–7/10” to “Acceptable for IEEE Access, 7.5–8.5/10”, which is a realistic acceptance range.  
So:  
Yes, this review is a genuine concern, and yes, it is entirely normal for a journal like IEEE Access.  
